Methodology Validation: Correlating Adherent Scalp Flaking Score (ASFS) With Phototrichogram for Scalp Dandruff Evaluation in Adult Subjects
Launched by NOVOBLISS RESEARCH PVT LTD · May 24, 2024
Trial Information
Current as of March 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 55 years (both inclusive).
- • Good general health as determined from recent medical history.
- • No previous history of adverse skin conditions, and not under any medication likely to interfere with the results.
- Exclusion Criteria:
- • Non-willing subjects and subjects with a history of allergies or specific allergic reactions upon using dermatological/cosmetic products will not be included.
About Novobliss Research Pvt Ltd
Novobliss Research Pvt Ltd is a forward-thinking clinical trial sponsor dedicated to advancing medical research and improving patient outcomes. With a strong emphasis on innovation and integrity, the company specializes in conducting Phase I to Phase IV clinical trials across a diverse range of therapeutic areas. Novobliss Research is committed to fostering collaboration among healthcare professionals, regulatory bodies, and industry partners to ensure the highest standards of clinical excellence. Their experienced team leverages cutting-edge technology and robust methodologies to deliver reliable data, driving the development of safe and effective treatments for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gandhinagar, Gujarat, India
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
